FDA-Cleared VR and Gamified Therapeutics
The US market in 2026 is dominated by FDA-cleared Virtual Reality (VR) platforms designed for home use. These systems turn vision therapy into an immersive gaming experience.
These devices use sophisticated algorithms to adjust difficulty in real-time. As the patient's "lazy eye" improves, the system subtly increases the visual load. Because these are games, children are significantly more likely to complete their prescribed "dosage" of therapy (often 30 minutes a day) compared to traditional patching. These platforms are now frequently covered by major US insurance providers under specific "Digital Health" codes.
3 Views